Prostate cancer: Body array versus endorectal coil MR imaging at 3T - Comparison of image quality, localization, and staging performance

Radiology

Volumn 244, Issue 1, 2007, Pages 184-195

  Heijmink, Stijn W T P J ^a   Fütterer, Jurgen J ^a   Hambrock, Thomas ^a   Takahashi, Satoru ^a   Scheenen, Tom W J ^a   Huisman, Henkjan J ^a   Hulsbergen Van De Kaa, Christina A ^a   Knipscheer, Ben C ^a   Kiemeney, Lambertus A L M ^a   Witjes, J Alfred ^a   Barentsz, Jelle O ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ADVANCED CANCER; AGED; ARTICLE; ARTIFACT; CANCER LOCALIZATION; CANCER STAGING; COMPARATIVE STUDY; DIAGNOSTIC ACCURACY; HISTOPATHOLOGY; HUMAN; IMAGE QUALITY; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE CANCER; PROSTATECTOMY; RADIOLOGIST; SENSITIVITY AND SPECIFICITY; THREE DIMENSIONAL IMAGING;

AREA UNDER CURVE; CLINICAL COMPETENCE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM STAGING; OBSERVER VARIATION; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; RECTUM; ROC CURVE; SENSITIVITY AND SPECIFICITY; STATISTICS, NONPARAMETRIC;

EID: 34250883974     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2441060425     Document Type: Article

References (41)

1. Carrol CL, Sommer FG, McNeal JE, Stamey TA. The abnormal prostate: MR imaging at 1.5 T with histopathologic correlation. Radiology 1987;163:521-525.
2. Claus FG, Hricak H, Hattery RR. Pretreatment evaluation of prostate cancer: role of MR imaging and 1H MR spectroscopy. RadioGraphics 2004;24(Spec Issue):S167-S180.
3. Hricak H, White S, Vigneron D, et al. Carcinoma of the prostate gland: MR imaging with pelvic phased-array coils versus integrated endorectal-pelvic phased-array coils. Radiology 1994;193:703-709.
4. Rouviere O, Hartman RP, Lyonnet D. Prostate MR imaging at high-field strength: evolution or revolution? Eur Radiol 2006;16:276-284.
5. Fütterer JJ, Scheenen TW, Huisman HJ, et al. Initial experience of 3 Tesla endorectal coil magnetic resonance imaging and 1H-spectroscopic imaging of the prostate. Invest Radiol 2004;39:671-680.
6. Sosna J, Pedrosa I, Dewolf WC, Mahallati H, Lenkinski RE, Rolsky NM. MR imaging of the prostate at 3 Tesla: comparison of an external phased-array coil to imaging with an endorectal coil at 1.5 Tesla. Acad Radiol 2004; 11:857-862.
7. Zelefsky MJ, Fuks Z, Leibel SA. Intensity-modulated radiation therapy for prostate cancer. Semin Radiat Oncol 2002;12:229-237.
8. Hong TS, Ritter MA, Tome WA, Harari PM. Intensity-modulated radiation therapy: emerging cancer treatment technology. Br J Cancer 2005;92:1819-1824.
9. Wang L, Hricak H, Kattan MW, Chen HN, Scardino PT, Kuroiwa K. Prediction of organ-confined prostate cancer: incremental value of MR Imaging and MR spectroscopic imaging to staging nomograms. Radiology 2006;238:597-603.
10. Jager GJ, Severens JL, Thornbury JR, de la Rosette JJ, Ruijs SH, Barentsz JO. Prostate cancer staging: should MR imaging be used? a decision analytic approach. Radiology 2000;215:445-451.
11. Engelbrecht MR, Jager GJ, Laheij RJ, Verbeek AL, van Lier HJ, Barentsz JO. Local staging of prostate cancer using magnetic resonance imaging: a meta-analysis. Eur Radiol 2002;12:2294-2302.
12. Fütterer JJ, Heijmink SW, Scheenen TW, et al. Prostate cancer: local staging at 3-T endorectal MR imaging - early experience. Radiology 2006;238:184-191.
13. Hennig J, Scheffler K. Hyperechoes. Magn Reson Med 2001;46:6-12.
14. Beyersdorff D, Taymoorian K, Knosel T, et al. MRI of Prostate cancer at. 1.5 and 3.0 T: comparison of image quality in tumor detection and staging. AJR Am J Roentgenol 2005; 185:1214-1220.
15. Cruz M, Tsuda K, Narumi Y, et al. Characterization of low-intensity lesions in the peripheral zone of prostate on pre-biopsy endorectal coil MR imaging. Eur Radiol 2002; 12:357-365.
16. Akin O, Sala E, Moskowitz CS, et al. Transition zone prostate cancers: features, detection, localization, and staging at endorectal MR imaging. Radiology 2006;239:784-792.
17. Li H, Sugimura K, Kaji Y, et al. Conventional MRI capabilities in the diagnosis of prostate cancer in the transition zone. AJR Am J Roentgenol 2006;186:729-742.
18. White S, Hricak H, Forstner R, et al. Prostate cancer: effect of postbiopsy hemorrhage on interpretation of MR images. Radiology 1995;195:385-390.
19. Yu KK, Scheidler J, Hricak H, et al. Prostate cancer: prediction of extracapsular extension with endorectal MR imaging and three-dimensional proton MR spectroscopic imaging. Radiology 1999;213:481-488.
20. Sala E, Akin O, Moskowitz CS, et al. Endorectal MR imaging in the evaluation of seminal vesicle invasion: diagnostic accuracy and multivariate feature analysis. Radiology 2006; 238:929-937.
21. Jager GJ, Ruijter ET, van de Kaa CA, et al. Local staging of prostate cancer with endorectal MR imaging: correlation with histopathology. AJR Am J Roentgenol 1996;166: 845-852.
22. Langlotz CP, Schnall MD, Malkowicz SB, Schwartz, JS. Cost-effectiveness of endorectal magnetic resonance imaging for the staging of prostate cancer. Acad Radiol 1996; 3(suppl 1):S24-S27.
23. Davis BJ, Pisansky TM, Wilson TM, et al. The radial distance of extraprostatic extension of prostate carcinoma: implications for prostate brachytherapy. Cancer 1999;85: 2630-2637.
24. Greene F, Page D, Fleming I, et al. AJCC Cancer staging manual. 6th ed. New York, NY: Springer Verlag, 2002.
25. Zakian KL, Sircar K, Hricak H, et al. Correlation of proton MR spectroscopic imaging with Gleason score based on step-section pathologic analysis after radical prostatectomy. Radiology 2005;234:804-814.
26. Fütterer JJ, Engelbrecht MR, Huisman HJ, et al. Staging prostate cancer with dynamic contrast-enhanced endorectal MR imaging prior to radical prostatectomy: experienced versus less experienced readers. Radiology 2005;237:541-549.
27. Futterer JJ, Heijmink SW, Scheenen TW, et al. Prostate cancer localization with dynamic contrast-enhanced MR imaging and proton MR spectroscopic imaging. Radiology 2006; 241:449-458.
28. Obuchowski NA, Lieber ML, Powell KA. Data analysis for detection and localization of multiple abnormalities with application to mammography. Acad Radiol 2000;7:516-525.
29. Rutter CM. Bootstrap estimation of diagnostic accuracy with patient-clustered data. Acad Radiol 2000;7:413-419.
30. Ihaka R, Gentleman R. R: a language for data analysis and graphics. J Comput Graph Stat 1996;5:299-314.
31. Bloch BN, Rofsky NM, Baroni RH, Marquis RP, Pedrosa I, Lenkinski RE. 3 Tesla magnetic resonance imaging of the prostate with combined pelvic phased-array and endorectal coils: initial experience. Acad Radiol 2004;11:863-867.
32. Mullerad M, Hricak H, Kuroiwa K, et al. Comparison of endorectal magnetic resonance imaging, guided prostate biopsy and digital rectal examination in the preoperative anatomical localization of prostate cancer. J Urol 2005;174:2158-2163.
33. Kurhanewicz J, Swanson MG, Nelson SJ, Vigneron DB. Combined magnetic resonance imaging and spectroscopic imaging approach to molecular imaging of prostate cancer. J Magn Reson Imaging 2002;16:451-463.
34. Engelbrecht MR, Huisman HJ, Laheij RJ, et al. Discrimination of prostate cancer from normal peripheral zone and central gland tissue by using dynamic contrast-enhanced MR imaging. Radiology 2003;229:248-254.
35. van Dorsten FA, van der Graaf M, Engelbrecht MR, et al. Combined quantitative dynamic contrast-enhanced MR imaging and (1)H MR spectroscopic imaging of human prostate cancer. J Magn Reson Imaging 2004;20:279-287.
36. Mullerad M, Hricak H, Wang L, Chen HN, Kattan MW, Scardino PT. Prostate cancer: detection of extracapsular extension by genitourinary and general body radiologists at MR imaging. Radiology 2004;232:140-146.
37. Cornud F, Flam T, Chauveinc L, et al. Extra-prostatic spread of clinically localized prostate cancer: factors predictive of pT3 tumor and of positive endorectal MR imaging examination results. Radiology 2002;224:203-210.
38. Nakashima J, Tanimoto A, Imai Y, et al. Endorectal MRI for prediction of tumor site, tumor size, and local extension of prostate cancer. Urology 2004;64:101-105.
39. Okihara K, Nakanishi H, Nakamura T, Mizutani Y, Kawauchi A, Miki T. Clinical characteristics of prostate cancer in Japanese men in the eras before and after serum prostate-specific antigen testing. Int J Urol 2005;12: 662-667.
40. de Bazelaire CM, Duhamel GD, Rofsky NM, Alsop DC. MR imaging relaxation times of abdominal and pelvic tissues measured in vivo at 3.0 T: preliminary results. Radiology 2004;230:652-659.
41. Hricak H, Wang L, Wei DC, et al. The role of preoperative endorectal magnetic resonance imaging in the decision regarding whether to preserve or resect neurovascular bundles during radical retropubic prostatectomy. Cancer 2004;100:2655-2663.